Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01762241
Other study ID # Wii-1-10-72-593-12
Secondary ID 1-10-72-593-12
Status Completed
Phase N/A
First received
Last updated
Start date February 2015
Est. completion date June 2018

Study information

Verified date February 2019
Source Hospitalsenheden Vest
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of 12 weeks systematically training using the Xbox Kinect system.

Outcome measures are made on physical function, quality of life, fatigue and metabolic parameters.


Description:

Patients will be recruited from the outpatient clinic at the urological department, Regionshospitalet Holstebro.

Patients who have been discharged from the outpatient clinic due to biochemical stabile cancer prostate disease will receive a letter with information about the study.

A research assistant will be responsible for randomization and test procedures. A physiotherapist will be responsible for instruction of the participants to the training and the Xbox system.

A student will be responsible for installation and collection of the Xbox system in the participants home.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender Male
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Prostate cancer requiring androgen deprivation therapy

- Androgen deprivation therapy for at least 3 month prior to inclusion

- Cognitive well-functioning in order to be able to answer questionnaires and train according to instructions

- Signed informed consent

Exclusion Criteria:

- Prostate cancer with metastasis to other regions than bones

- Strength- or cardiovascular training 2 times or more per week prior to inclusion

- Haemoglobin percentage less than 6,1 mmol/l

- Any mental or physical condition that makes the patient unfit for participation

- Men in risk of getting an osteoporotic fracture due to long-term treatment with steroids or earlier fractures due to minimal trauma

- Participation in other studies

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Home based training using the Xbox Kinect system
Home based training 3 times a week for 12 weeks using the Xbox Kinect system

Locations

Country Name City State
Denmark Urinvejskirurgisk afdeling, Aarhus Universitetshospital, Skejby Aarhus
Denmark Regionshospitalet Holstebro, Urinvejskirurgisk afdeling Holstebro
Denmark Urologisk afdeling, Regionshospitalet Viborg Viborg

Sponsors (1)

Lead Sponsor Collaborator
Hospitalsenheden Vest

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary The effect of 12 weeks systematically training with the Xbox Kinect system on physical function 6 min walk test Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect on body composition Method: BIoelectrical impedance analysis Bioelectrical impedance Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on physical function Leg extensor power Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on fatigue Fatigue measured using the Functional Assessment of Canter Therapy-Fatigue questionnaire Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on quality of life Quality of life measured using the Functional Assessment of Canter Therapy-Prostate questionnaire Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Waist circumference (cm) Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Blood pressure (mmHg) Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Body weight (kg) Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Blood glucose (mmol/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Plasma triglyceride (mmol/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Plasma cholesterol (mmol/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Plasma High-density lipoprotein (HDL-cholesterol) (mmol/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Plasma Low-density lipoprotein (LDL-cholesterol) (mmol/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Leptin (µg/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Adiponectin (mg/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters Leptin:Adiponectin ratio Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on the prevalence of the metabolic syndrome The five components of the metabolic syndrome: blood glucose, triglyceride, HDL-cholesterol, waist circumference, blood pressure Change from baseline to week 12
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on insulin Insulin (pmol/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on insulin resistance Homeostasis model assessment for insulin resistance (HOMA-IR) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor-I (IGF-I), bioactive IGF, and IGF-II IGF-I, bioactive IGF and IGF-II (µg/L) Change from baseline to week 12 and week 24
Secondary The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor Binding Protein 1-3 (IGFBP 1-3) IGFBP 1-3 (µg/L) Change from baseline to week 12 and week 24
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A